Libera Bio
PrivateLast Round
Seed
Jul 4, 2022
Total Funding Raised
$1.34M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Libera Bio is a biopharmaceutical company that develops novel cancer therapeutics by leveraging its proprietary Multifunctional Polymeric Nanoparticles (MPN Technology®) to deliver biologics and small molecules to intracellular targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Libera Bio Comparables
Compare Libera Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iDEL Therapeutics | 89% | |
| Xelcis Bio, Inc. | 85% | |
| Polar NanoPharma | 82% |
Libera Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 4, 2022 |
Key People
Founding team and executive leadership
Libera Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nowture | Seed |
| Rosp Corunna | Seed |
| Xesgalicia | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 105% MoM, reaching 3.1K.
- May 15, 2026
Monthly visitors increased 59% MoM.
Libera Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Libera Bio's valuation, stock price, and market status.
Is Libera Bio a public or private company?
Libera Bio is a private company.
What is the current stock price of Libera Bio?
Libera Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Libera Bio worth (valuation)?
Valuation information for Libera Bio is not publicly available.
Can I buy Libera Bio stock?
Libera Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Libera Bio's last funding round?
Libera Bio's most recent funding round was Seed on July 15, 2022.
Who are the main investors in Libera Bio?
Key investors in Libera Bio include Nowture.
Will Libera Bio IPO soon?
No public IPO plans have been announced for Libera Bio.
How can I track Libera Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Libera Bio's secondary market activity and sign up for updates.